Elan

NYSE: ELN
Source: ThinkstockInvestors make big money in biotechnology stocks when they focus on areas that cut across a wide swath of the population. From obesity to food allergies to prostate cancer, the top...
Lee Jackson
Source: ThinkstockStephen A. Cohen, the founder and owner of SAC Capital Advisors LLC, has been charged by the U.S. Securities and Exchange Commission (SEC) with “failing reasonably to supervise...
Paul Ausick
Source: ThinkstockOnce again, the Wall Street conference calendar is heating up. Next week is the widely attended Jefferies Global Healthcare Conference in New York City. Following the success of...
Lee Jackson
Source: Jon OggIt may be the weekend, and the DJIA hit a new high this last week, but there is no such thing as any rest for the wicked. 24/7 Wall St. has identified 13 must-read weekend stock...
Jon C. Ogg
Source: Jon OggThese are some of this Monday’s top analyst upgrades, downgrades and initiations seen from Wall St. research calls.Amgen Inc. (NASDAQ: AMGN) cut to Market Perform at William...
Jon C. Ogg
Source: ThinkstockBiogen Idec Inc. (NASDAQ: BIIB) may be a half decade or so late on this move, but as the saying goes “better late than never.” The biotech and drug company is the leader in...
Jon C. Ogg
Drugmaker Eli Lilly & Co. (NYSE: LLY) announced this morning that the company’s solanezumab treatment for Alzheimer’s disease failed to meet both the cognitive and functional endpoints in...
Paul Ausick
Source: Jon OggThese are some of the top analyst upgrades, downgrades and initiations seen from Wall St. research calls this Tuesday morning.Changyou.com Ltd. (NASDAQ: CYOU) started as Buy at...
Jon C. Ogg
Elan Corporation, plc (NYSE: ELN) may be surging on news that it is going to spin off its drug research unit, but now there is something else to consider.  Elan could be getting closer and closer...
Jon C. Ogg
The three major US stock indexes opened roughly flat this morning as Spanish 10-year bond yields rose to 7.5% and Moody’s cut Germany’s outlook to ‘negative’ after the markets closed last...
Paul Ausick
A new treatment for Alzheimer’s disease from Pfizer Inc. (NYSE: PFE) and partner Elan Corp. plc (NYSE: ELN) has failed a late-stage trial in patients with mild-to-moderate cases of the disease and...
Paul Ausick
Alkermes plc (NASDAQ: ALKS) has filed its paperwork with the Securities and Exchange Commission for the resale covering the potential future sales by a subsidiary of Elan Corporation, plc (NYSE:...
Jon C. Ogg
Source: Jon OggThese are some of the top analyst upgrades, downgrades, and initiations seen from Wall Street brokerage and research firms this Thursday morning.Amgen Inc. (NASDAQ: AMGN) Cut to...
Jon C. Ogg
These are some of the top analyst upgrades, downgrades, and initiations seen from Wall Street research calls this Thursday morning. Affymetrix Inc. (NASDAQ: AFFX) Raised to Neutral from Sell with a...
Jon C. Ogg
Active traders and day traders have many stocks to choose from this Wednesday morning. We are tracking news and  moves in shares of Elan Corporation, plc. (NYSE: ELN), Sprint Nextel Corporation...
Douglas A. McIntyre